FDA DEVICE FACTS
Simplera Sync Sensor, Guardian 4 Sensor
Medtronic Minimed, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Simplera Sync Sensor The Simplera Sync sensor is a continuous glucose monitor (CGM) intended for use with compatible Medtronic automated insulin dosing (AID) systems to monitor glucose levels for the management of diabetes.
The Simplera Sync sensor is not intended to be used directly to make therapy adjustments while the AID system is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync sensor.
The Simplera Sync sensor is indicated for persons 7 years and older for insertion in arm.
The Simplera Sync sensor is intended for single use and requires a prescription.
The Simplera Sync sensor can be used one time and has a life of up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly.
The Simplera Sync sensor is indicated for the management of diabetes in persons ages 7 years and older.
Guardian 4 Sensor The Guardian 4 sensor is intended to monitor glucose levels for the management of diabetes for persons ages 7 years and older. It is indicated for use as an adjunctive device to complement, not replace, information obtained from the standard blood glucose monitoring devices. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to 7 days of continuous use. Refer to the system user guide for treatment decisions.
The Guardian 4 sensor continuous glucose monitor (CGM) is also intended for use with Guardian 4 Transmitters and compatible Medtronic automated insulin dosing (AID) systems to monitor glucose levels for the management of diabetes.
The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the AID system is operating in manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor.
The Guardian 4 sensor is indicated for persons 7 years and older for insertion in arm.
The sensor is intended for single use and requires a prescription. Guardian 4 Transmitter The Guardian 4 transmitter is intended for use with Guardian 4 sensors and compatible Medtronic automated insulin dosing (AID) systems to monitor glucose levels for the management of diabetes.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。